Hypofractionated Intensity-Modulated Radiotherapy (IMRT) for Prostate Cancer Using Patient-Specific Cancer Biology

被引：0
|
作者：
Her, E. [1 ]
Haworth, A. [2 ]
Kennedy, A. [3 ]
Reynolds, H. [4 ]
Sun, Y. [2 ]
Bangert, M. [5 ]
Williams, S. [4 ]
Ebert, M. [6 ]
机构：
[1] Univ Western Australia, Perth, WA, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Sir Charles Gairdner Hosp, Perth, WA 6009, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] German Canc Res Ctr, Heidelberg, Germany
[6] Univ Western Australia, Nedlands, WA, Australia
来源：
MEDICAL PHYSICS | 2018年 / 45卷 / 06期
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
TU-D-KDBRA
引用
收藏
页码：E507 / E507
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of chemoradiotherapy using intensity-modulated radiotherapy (IMRT) for locally advanced esophageal cancer
    Nakamura, M.
    Oda, K.
    Aizawa, T.
    Taguchi, K.
    Kasai, N.
    Ito, Y.
    Kamikawa, H.
    Tauchi, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S587 - S587
  • [42] Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
    Wang, Michael
    Pearcey, Robert
    Pervez, Nadeem
    Yee, Don
    Mihai, Alina
    Patel, Samir
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [43] Outcomes of dose-escalation using an image-guided, hypofractionated, intensity-modulated radiotherapy boost for localized prostate cancer
    Shridhar, R.
    Perry, D. J.
    Bolton, S.
    Joiner, M.
    Forman, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S387 - S387
  • [44] Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer
    Quon, Harvey
    Cheung, Patrick C. F.
    Loblaw, D. Andrew
    Morton, Gerard
    Pang, Geordi
    Szumacher, Ewa
    Danjoux, Cyril
    Choo, Richard
    Kiss, Alex
    Mamedov, Alexandre
    Deabreu, Andrea
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 617 - 623
  • [45] Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer
    Cheung, P
    Sixel, K
    Morton, G
    Loblaw, DA
    Tirona, R
    Pang, G
    Choo, R
    Szumacher, E
    DeBoer, G
    Pignol, JP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02): : 418 - 425
  • [46] Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon
    Kim, Hyunjung
    Kim, Jun Won
    Hong, Sung Joon
    Rha, Koon Ho
    Lee, Chang-Geol
    Yang, Seung Choul
    Choi, Young Deuk
    Suh, Chang-Ok
    Cho, Jaeho
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (03): : 187 - 197
  • [47] Effectiveness and toxicity of the intensity modulated radiotherapy (IMRT) as hypofractionated boost with prostate carcinoma
    Kosakowski, J.
    Welzel, G.
    Abo-Madyan, Y.
    Mai, S.
    Wertz, H.
    Wenz, F.
    Lohr, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 21 - 21
  • [48] Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer
    Naismith, O.
    Mayles, H.
    Bidmead, M.
    Clark, C. H.
    Gulliford, S.
    Hassan, S.
    Khoo, V
    Roberts, K.
    South, C.
    Hall, E.
    Dearnaley, D.
    CLINICAL ONCOLOGY, 2019, 31 (09) : 611 - 620
  • [49] Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer
    Hoffman, Karen E.
    Voong, K. Ranh
    Levy, Lawrence B.
    Allen, Pamela K.
    Choi, Seungtaek
    Schlembach, Pamela J.
    Lee, Andrew K.
    McGuire, Sean E.
    Quynh Nguyen
    Pugh, Thomas J.
    Frank, Steven J.
    Kudchadker, Rajat J.
    Du, Weiliang
    Kuban, Deborah A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (29) : 2943 - +
  • [50] Intensity-modulated radiotherapy (IMRT) for prostate cancer at Ghent university hospital (GUH): First report on late toxicity
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 168 - 168
12345